Cancer–neuronal crosstalk and the startups working to silence it
Elie Dolgin • February 7, 2020
Investors back ‘cancer neuroscience’ outfits as the field breaks out from academia.
Continue reading here.
‘Directed’ evolution in the laboratory creates an editing tool that outperforms classic CRISPR systems.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.